Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters

Stopped early

Conditions studied: Cancer

In brief

This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.

Key facts

Study ID

NCT01586026

Run by

C. R. Bard

People needed

171

Starts

2012-04-01

Expected to finish

2012-11-01

Last updated by the study team

2016-08-23

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, age ≥ 21 years
• Subject has an implanted Bard port with a distally-valved catheter
• Subject has maintenance port flushes with heparin/heparinized saline or normal saline
• Subject is post infusional cancer therapy (solid tumor or hematologic)
• Subject has signed a HIPAA Authorization to use and disclose PHI

You may not qualify if…

• Subject is having port maintenance flushes/locks with citrate.

Where it is running

• Quincy Medical Group — Quincy, Illinois, United States
• Willis Knighton Cancer Center — Shreveport, Louisiana, United States
• St. Luke's Hospital — Chesterfield, Missouri, United States
• Southeast Nebraska Cancer Center — Lincoln, Nebraska, United States
• Alegent Research Center — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.